| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 Mar 2026 | 27 Mar 2026 |
| Outcome of the meeting of Board of Directors of Novartis India Limited (the Company) held today i.e. Friday, March 27, 2026 inter-alia to approve the appointment of Ms. Gowree Gokhale (DIN: 09351661) as an additional Director (designated as Non-Executive and Independent Director) of the company w.e.f. April 01,2026 and note completion of tenure of Ms. Sandra Martyres w.e.f. April 18, 2026. | ||
| Board Meeting | 28 Jan 2026 | 30 Dec 2025 |
| Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 inter alia to consider and approve The Unaudited Financial Results for the quarter ended December 31 2025. Outcome of the Meeting of the Board of Directors of Novartis India Limited (the Company) held on Wednesday, January 28, 2026. (As Per BSE Announcement Dated On : 28.01.2026) | ||
| Board Meeting | 28 Oct 2025 | 30 Sep 2025 |
| Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2025 inter alia to consider and approve The Meeting of the Board of Directors of Novartis India Limited is scheduled to be held on Tuesday October 28 2025 to inter alia consider the Unaudited Financial Results for the half year and quarter ended September 30 2025. Outcome of the Board Meeting held on Tuesday, October 28, 2025, to inter alia consider and approve the Financial Statements for the Quarter and Half year ended September 30, 2025. (As per BSE Announcement dated on: 28.10.2025) | ||
| Board Meeting | 29 Jul 2025 | 30 Jun 2025 |
| Quarterly Results Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2025 and signing of Unaudited Financial Results, submission to the Stock Exchange and its Publication. (As Per BSE Announcement Dated on 30.06.2025) Intimation about the Outcome of the Board Meeting held on July 29, 2025, inter alia for the approval of the unaudited Financial Statements for the Quarter ending as on June 30, 2025. (As Per BSE Announcement Dated on: 29/07/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
